Perspective Therapeutics, Inc. Quarterly Nonoperating Income (Expense) in USD from Q3 2010 to Q3 2024

Taxonomy & unit
us-gaap: USD
Description
The aggregate amount of income or expense from ancillary business-related activities (that is to say, excluding major activities considered part of the normal operations of the business).
Summary
Perspective Therapeutics, Inc. quarterly/annual Nonoperating Income (Expense) history and growth rate from Q3 2010 to Q3 2024.
  • Perspective Therapeutics, Inc. Nonoperating Income (Expense) for the quarter ending September 30, 2024 was $3.51M, a 1873% increase year-over-year.
  • Perspective Therapeutics, Inc. Nonoperating Income (Expense) for the twelve months ending September 30, 2024 was $7.77M, a 536% increase year-over-year.
  • Perspective Therapeutics, Inc. annual Nonoperating Income (Expense) for 2023 was $835K, a 35.1% increase from 2022.
  • Perspective Therapeutics, Inc. annual Nonoperating Income (Expense) for 2022 was $618K, a 947% increase from 2021.
  • Perspective Therapeutics, Inc. annual Nonoperating Income (Expense) for 2021 was $59K, a 96.7% increase from 2020.
Nonoperating Income (Expense), Trailing 12 Months (USD)
Nonoperating Income (Expense), Quarterly (USD)
Nonoperating Income (Expense), YoY Quarterly Growth (%)
Period TTM Value Value YoY Chg Change % Start Date End Date Report Filed
Q3 2024 $7.77M $3.51M +$3.33M +1873% Jul 1, 2024 Sep 30, 2024 10-Q 2024-11-12
Q2 2024 $4.44M $3.05M +$2.78M +1038% Apr 1, 2024 Jun 30, 2024 10-Q 2024-08-13
Q1 2024 $1.66M $1.18M +$824K +231% Jan 1, 2024 Mar 31, 2024 10-Q 2024-05-15
Q4 2023 $835K $33K -$388K -92.2% Oct 1, 2023 Dec 31, 2023 10-K 2024-03-28
Q3 2023 $1.22M $178K +$38K +27.1% Jul 1, 2023 Sep 30, 2023 10-Q 2024-11-12
Q2 2023 $1.19M $268K +$240K +857% Apr 1, 2023 Jun 30, 2023 10-Q 2024-08-13
Q1 2023 $945K $356K +$327K +1128% Jan 1, 2023 Mar 31, 2023 10-Q 2024-05-15
Q4 2022 $618K $421K +$390K +1258% Oct 1, 2022 Dec 31, 2022 10-K 2024-03-28
Q3 2022 $228K $140K +$109K +352% Jul 1, 2022 Sep 30, 2022 10-Q 2023-11-14
Q2 2022 $119K $28K -$4K -12.5% Apr 1, 2022 Jun 30, 2022 10-Q 2023-08-11
Q1 2022 $123K $29K +$8K +38.1% Jan 1, 2022 Mar 31, 2022 10-Q 2023-05-15
Q4 2021 $115K $31K +$26K +520% Oct 1, 2021 Dec 31, 2021 10-Q 2022-02-09
Q3 2021 $89K $31K +$30K +3000% Jul 1, 2021 Sep 30, 2021 10-Q 2022-11-14
Q2 2021 $59K $32K +$31K +3100% Apr 1, 2021 Jun 30, 2021 10-KT 2023-05-01
Q1 2021 $28K $21K +$18K +600% Jan 1, 2021 Mar 31, 2021 10-Q 2022-05-13
Q4 2020 $10K $5K -$1K -16.7% Oct 1, 2020 Dec 31, 2020 10-Q 2022-02-09
Q3 2020 $11K $1K -$19K -95% Jul 1, 2020 Sep 30, 2020 10-Q 2021-11-10
Q2 2020 $30K $1K -$48K -98% Apr 1, 2020 Jun 30, 2020 10-KT 2023-05-01
Q1 2020 $78K $3K -$33K -91.7% Jan 1, 2020 Mar 31, 2020 10-Q 2021-05-14
Q4 2019 $111K $6K -$9K -60% Oct 1, 2019 Dec 31, 2019 10-Q 2021-02-09
Q3 2019 $120K $20K +$10K +100% Jul 1, 2019 Sep 30, 2019 10-Q 2020-11-13
Q2 2019 $110K $49K +$38K +345% Apr 1, 2019 Jun 30, 2019 10-K 2021-09-27
Q1 2019 $72K $36K +$29K +414% Jan 1, 2019 Mar 31, 2019 10-Q 2020-05-13
Q4 2018 $43K $15K +$10K +200% Oct 1, 2018 Dec 31, 2018 10-Q 2020-02-12
Q3 2018 $33K $10K +$4K +66.7% Jul 1, 2018 Sep 30, 2018 10-Q 2019-11-13
Q2 2018 $29K $11K +$1K +10% Apr 1, 2018 Jun 30, 2018 10-K 2020-09-25
Q1 2018 $28K $7K -$22K -75.9% Jan 1, 2018 Mar 31, 2018 10-Q 2019-05-10
Q4 2017 $50K $5K -$24K -82.8% Oct 1, 2017 Dec 31, 2017 10-Q 2019-02-13
Q3 2017 $74K $6K -$71K -92.2% Jul 1, 2017 Sep 30, 2017 10-Q 2018-11-09
Q2 2017 $145K $10K -$59K -85.5% Apr 1, 2017 Jun 30, 2017 10-K 2019-09-27
Q1 2017 $204K $29K -$103K -78% Jan 1, 2017 Mar 31, 2017 10-Q 2018-05-04
Q4 2016 $307K $29K -$70K -70.7% Oct 1, 2016 Dec 31, 2016 10-Q 2018-02-09
Q3 2016 $377K $77K +$6K +8.45% Jul 1, 2016 Sep 30, 2016 10-Q 2017-11-14
Q2 2016 $371K $69K -$937 -1.34% Apr 1, 2016 Jun 30, 2016 10-K 2018-09-26
Q1 2016 $372K $132K +$34.5K +35.4% Jan 1, 2016 Mar 31, 2016 10-Q 2017-05-10
Q4 2015 $337K $99K -$14.4K -12.7% Oct 1, 2015 Dec 31, 2015 10-Q 2017-02-09
Q3 2015 $352K $71K -$304K -81.1% Jul 1, 2015 Sep 30, 2015 10-Q 2016-11-09
Q2 2015 $656K $69.9K +$427K Apr 1, 2015 Jun 30, 2015 10-K 2017-09-28
Q1 2015 $229K $97.5K +$1.19M Jan 1, 2015 Mar 31, 2015 10-Q 2016-05-10
Q4 2014 -$963K $113K -$4.04K -3.44% Oct 1, 2014 Dec 31, 2014 10-Q 2016-02-09
Q3 2014 -$959K $375K +$412K Jul 1, 2014 Sep 30, 2014 10-Q 2015-11-09
Q2 2014 -$1.37M -$357K -$385K -1409% Apr 1, 2014 Jun 30, 2014 10-K 2016-09-09
Q1 2014 -$986K -$1.09M -$1.2M -1103% Jan 1, 2014 Mar 31, 2014 10-Q 2015-05-15
Q4 2013 $217K $117K +$172K Oct 1, 2013 Dec 31, 2013 10-Q 2015-02-17
Q3 2013 $45.1K -$36.4K -$166K -128% Jul 1, 2013 Sep 30, 2013 10-Q 2014-11-14
Q2 2013 $211K $27.3K +$385K Apr 1, 2013 Jun 30, 2013 10-K 2015-09-14
Q1 2013 -$174K $109K -$101K -48% Jan 1, 2013 Mar 31, 2013 10-Q 2014-05-15
Q4 2012 -$73K -$54.9K -$218K -134% Oct 1, 2012 Dec 31, 2012 10-Q 2014-02-14
Q3 2012 $145K $129K +$36.1K +38.9% Jul 1, 2012 Sep 30, 2012 10-Q 2013-11-14
Q2 2012 $109K -$357K -$412K -756% Apr 1, 2012 Jun 30, 2012 10-K 2013-09-30
Q1 2012 $521K $210K +$547K Jan 1, 2012 Mar 31, 2012 10-Q 2013-05-15
Q4 2011 -$26.1K $163K -$243K -59.8% Oct 1, 2011 Dec 31, 2011 10-Q 2013-02-14
Q3 2011 $217K $93K +$96.4K Jul 1, 2011 Sep 30, 2011 10-Q 2012-11-14
Q2 2011 $121K $54.4K Apr 1, 2011 Jun 30, 2011 10-K/A 2012-10-26
Q1 2011 -$337K Jan 1, 2011 Mar 31, 2011 10-Q 2012-05-15
Q4 2010 $407K Oct 1, 2010 Dec 31, 2010 10-Q 2012-02-14
Q3 2010 -$3.4K Jul 1, 2010 Sep 30, 2010 10-Q/A 2011-12-13
* An asterisk sign (*) next to the value indicates that the value is likely invalid.